Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126756151 | 12675615 | 1 | I | 20160812 | 20160823 | 20160823 | EXP | US-JNJFOC-20160811220 | JOHNSON AND JOHNSON | 0.00 | E | F | Y | 0.00000 | 20160823 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126756151 | 12675615 | 1 | PS | LOPERAMIDE HYDROCHLORIDE. | LOPERAMIDE HYDROCHLORIDE | 1 | Oral | N | U | P94425 | 19860 | CAPLET | |||||||
| 126756151 | 12675615 | 2 | SS | LOPERAMIDE HYDROCHLORIDE. | LOPERAMIDE HYDROCHLORIDE | 1 | Oral | AS NEEDED. | N | U | P94425 | 19860 | 2 | MG | CAPLET | ||||
| 126756151 | 12675615 | 3 | SS | TIKOSYN | DOFETILIDE | 1 | Oral | TAKES AT 9 A.M AND 9 P.M. | UNKNOWN | 0 | .25 | MG | CAPSULE | Q12H | |||||
| 126756151 | 12675615 | 4 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | STARTED YEARS AGO | 0 | 40 | MG | CAPSULE | QD | ||||||
| 126756151 | 12675615 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | STARTED YEARS AGO | 0 | 40 | MG | CAPSULE | QD | ||||||
| 126756151 | 12675615 | 6 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 100 MCG TABLET DAILY??STARTED SEVERAL YEARS AGO. | 0 | 100 | UG | TABLET | |||||||
| 126756151 | 12675615 | 7 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 100 MCG TABLET DAILY??STARTED SEVERAL YEARS AGO. | 0 | 100 | UG | TABLET | |||||||
| 126756151 | 12675615 | 8 | C | LIVALO | PITAVASTATIN CALCIUM | 1 | Oral | ONCE DAILY IN EVENING??STARTED ABOUT 6 MONTHS AGO | 0 | 4 | MG | TABLET | QD | ||||||
| 126756151 | 12675615 | 9 | C | MAGNESIUM | MAGNESIUM | 1 | Oral | MORNING AND NIGHT.HAS BEEN ON IT FOR A WHILE.DOSE INCREASED FROM ONCE DAILY TO TWICE DAILY. | 0 | 400 | MG | TABLET | BID | ||||||
| 126756151 | 12675615 | 10 | C | LASIX | FUROSEMIDE | 1 | Oral | 40 MG PILL ONCE DAILY. | 0 | 40 | MG | UNSPECIFIED | QD | ||||||
| 126756151 | 12675615 | 11 | C | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | MORNING AND NIGHT | 0 | 150 | MG | CAPSULE | BID | ||||||
| 126756151 | 12675615 | 12 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 50 MG 1 1/2 TABLETS BY MOUTH TWICE DAILY | 0 | 50 | MG | TABLETS | BID | ||||||
| 126756151 | 12675615 | 13 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 0 | 25 | MG | TABLET | QD | |||||||
| 126756151 | 12675615 | 14 | C | CALCIUM | CALCIUM | 1 | Oral | 0 | TABLET | ||||||||||
| 126756151 | 12675615 | 15 | C | CALCIUM | CALCIUM | 1 | Oral | 0 | TABLET | ||||||||||
| 126756151 | 12675615 | 16 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | 0 | TABLET | ||||||||||
| 126756151 | 12675615 | 17 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | 0 | TABLET | ||||||||||
| 126756151 | 12675615 | 18 | C | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | Oral | TAKING FOR YEARS. | 0 | 25 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126756151 | 12675615 | 2 | Diarrhoea |
| 126756151 | 12675615 | 3 | Atrial fibrillation |
| 126756151 | 12675615 | 4 | Polyp |
| 126756151 | 12675615 | 5 | Gastrooesophageal reflux disease |
| 126756151 | 12675615 | 6 | Thyroxine decreased |
| 126756151 | 12675615 | 7 | Tri-iodothyronine free decreased |
| 126756151 | 12675615 | 8 | Blood triglycerides increased |
| 126756151 | 12675615 | 9 | Blood magnesium decreased |
| 126756151 | 12675615 | 10 | Cardiac failure congestive |
| 126756151 | 12675615 | 11 | Cerebrovascular accident prophylaxis |
| 126756151 | 12675615 | 12 | Palpitations |
| 126756151 | 12675615 | 13 | Diuretic therapy |
| 126756151 | 12675615 | 14 | Radiotherapy |
| 126756151 | 12675615 | 15 | Mastectomy |
| 126756151 | 12675615 | 16 | Radiotherapy |
| 126756151 | 12675615 | 17 | Mastectomy |
| 126756151 | 12675615 | 18 | Vertigo |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126756151 | 12675615 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126756151 | 12675615 | Atrial fibrillation | |
| 126756151 | 12675615 | Diarrhoea | |
| 126756151 | 12675615 | Dizziness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126756151 | 12675615 | 2 | 20160804 | 0 | ||
| 126756151 | 12675615 | 3 | 201103 | 0 | ||
| 126756151 | 12675615 | 10 | 2011 | 0 | ||
| 126756151 | 12675615 | 11 | 2011 | 0 | ||
| 126756151 | 12675615 | 14 | 2007 | 0 | ||
| 126756151 | 12675615 | 15 | 2007 | 0 | ||
| 126756151 | 12675615 | 16 | 2007 | 0 | ||
| 126756151 | 12675615 | 17 | 2007 | 0 |